Navigation Links
Cambridge Semantics to Present on Smart Data and Competitive Intelligence Informatics at 2013 Pharma CI Conference & Exposition
Date:8/22/2013

BOSTON (PRWEB) August 22, 2013

Cambridge Semantics, leading provider of smart data solutions for the pharmaceutical industry, today announced its participation in the 2013 Pharma CI Conference & Exposition. Lee Feigenbaum, Vice President of Marketing and Technology for Cambridge Semantics, will present on pharma competitive intelligence (CI) solutions to automate data gathering, investigation and analytics to conference delegates. In addition, Cambridge Semantics is exhibiting at the conference.

When:
September 18, 2013
9:00 a.m. – 9:35 a.m.

Where:
Pharma CI Conference & Exhibition
Hilton East Brunswick Hotel
3 Tower Center Blvd.
East Brunswick, New Jersey 08816

Details: Large pharmaceutical organizations, like companies in many industries, face challenges with enterprise data management and end user data consumption. At Pharma CI Conference & Exposition, Feigenbaum’s presentation will introduce the concept of “CI Informatics,” technology solutions dedicated to gathering and distributing high-quality competitive intelligence information. Feigenbaum’s presentation will provide examples of CI Informatics in use based on Cambridge Semantics’ award-winning Anzo Pharma Competitive Intelligence solution.

Using semantic technology, Anzo proactively gathers and routes relevant and targeted CI information to the right people at the right time, from the right information sources – whether internal or external to the company, structured or unstructured. The software can be used for intelligence gathering across a number of use cases, including compound licensing, biopartnering, market intelligence, comparative effectiveness research, drug repositioning, self-service competitive intelligence reporting and analytics, and more.

Cambridge Semantics’ Anzo platform has been deployed by R&D CI teams, business development and sourcing teams, marketing groups and knowledge management teams at a number of leading pharma companies, including Merck, Lilly, Novartis, Biogen and others.

Media and analysts interested in a briefing with Cambridge Semantics, please contact Lora Friedrichsen at Cambridge(at)globalresultspr(dot)com or +1 949 608 0276.

About Cambridge Semantics

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics or Facebook.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051384.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioMed Realty Acquires 320 Charles In Cambridge, MA
2. Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
3. Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill
4. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
5. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
6. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
7. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
8. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
9. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... ... USDM Life Sciences , the leading risk management, technological innovation and ... announce Holger Braemer as Vice President of its Europe division and Managing ... , Braemer is an integral part of USDM’s expansion of services and solutions for ...
(Date:4/20/2017)... - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or ... Congress ("ILC") 2017 of the European Association for the Study ... on the positive effects of PBI-4050 on reduction of non-alcoholic ... syndrome. ... Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This extensive ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... unique intellectual property (IP) sharing and commercialization model. , The Center for Advancing ... main component of this effort is bringing the IP to the attention of ...
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
Breaking Biology Technology:
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
Breaking Biology News(10 mins):